Target Price | $68.13 |
Price | $32.28 |
Potential |
111.04%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target SpringWorks Therapeutics Inc 2025 .
The average SpringWorks Therapeutics Inc target price is $68.13.
This is
111.04%
register free of charge
$80.00
147.83%
register free of charge
$58.00
79.68%
register free of charge
|
|
A rating was issued by 8 analysts: 8 Analysts recommend SpringWorks Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the SpringWorks Therapeutics Inc stock has an average upside potential 2025 of
111.04%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 5.45 | 195.17 |
3,481.05% | ||
EBITDA Margin | -6,263.30% | -142.10% |
97.73% | ||
Net Margin | -7,017.23% | -126.27% |
98.20% |
7 Analysts have issued a sales forecast SpringWorks Therapeutics Inc 2024 . The average SpringWorks Therapeutics Inc sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an SpringWorks Therapeutics Inc EBITDA forecast 2024. The average SpringWorks Therapeutics Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 SpringWorks Therapeutics Inc Analysts have issued a net profit forecast 2024. The average SpringWorks Therapeutics Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -5.15 | -3.32 |
1.15% | 35.53% | |
P/E | negative | |
EV/Sales | 10.35 |
7 Analysts have issued a SpringWorks Therapeutics Inc forecast for earnings per share. The average SpringWorks Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the SpringWorks Therapeutics Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
SpringWorks Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.